Diagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDR.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 2822893)

Published in Int J Geriatr Psychiatry on March 01, 2010

Authors

Ranjan Duara1, David A Loewenstein, Maria T Greig-Custo, Ashok Raj, Warren Barker, Elizabeth Potter, Elizabeth Schofield, Brent Small, John Schinka, Yougui Wu, Huntington Potter

Author Affiliations

1: Wien Center for Alzheimer's Disease & Memory Disorders, Mount. Sinai Medical Center, Miami Beach, FL, USA. ranjan-duara@msmc.com

Articles cited by this

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41

The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72

Indices of relative weight and obesity. J Chronic Dis (1972) 6.60

The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord (2007) 5.01

Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr (1997) 4.87

MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology (2002) 4.67

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50

Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04

Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79

Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Arch Neurol (2008) 2.25

Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry (2006) 2.10

Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand (2002) 1.75

Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology (2008) 1.74

Reliability of clinical nurse specialists in the staging of dementia. Arch Neurol (1989) 1.41

Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology (2004) 1.31

Estimating the validity of the clinical Dementia Rating Scale: the CERAD experience. Consortium to Establish a Registry for Alzheimer's Disease. Aging (Milano) (1996) 1.30

Neurofibrillary pathology--correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging (1997) 1.30

Interrater reliability of the Clinical Dementia Rating in a multicenter trial. J Am Geriatr Soc (2000) 1.19

Evaluation of cognitive impairment in older adults: combining brief informant and performance measures. Arch Neurol (2007) 1.11

Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease. J Comput Assist Tomogr (2009) 1.08

Reliability of monitoring the clinical dementia rating in multicenter clinical trials. Alzheimer Dis Assoc Disord (2004) 1.07

Cognitive profiles in Alzheimer's disease and in mild cognitive impairment of different etiologies. Dement Geriatr Cogn Disord (2006) 0.98

Utility of the clinical dementia rating in Asian populations. Clin Med Res (2007) 0.93

Mild cognitive impairment or questionable dementia? Arch Neurol (2000) 0.90

Brief informant screening test for mild cognitive impairment and early Alzheimer's disease. Dement Geriatr Cogn Disord (2006) 0.89

Articles by these authors

The effect of a family therapy and technology-based intervention on caregiver depression. Gerontologist (2003) 2.09

Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08

Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. J Alzheimers Dis (2009) 1.91

Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol (2011) 1.84

Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J Infect Dis (2009) 1.80

Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One (2007) 1.58

Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med (2006) 1.52

Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol Aging (2006) 1.48

Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study). Cancer Epidemiol Biomarkers Prev (2011) 1.37

LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's disease. PLoS One (2010) 1.32

Developmental and vascular risk factors for Alzheimer's disease. Neurobiol Aging (2005) 1.28

Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studies. Am J Geriatr Psychiatry (2010) 1.27

Nonpharmacological cognitive interventions in aging and dementia. J Geriatr Psychiatry Neurol (2007) 1.25

Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem (2007) 1.22

GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. J Alzheimers Dis (2010) 1.22

Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates. Am J Geriatr Psychiatry (2010) 1.19

Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. Am J Geriatr Psychiatry (2011) 1.19

Caregiver appraisals of functional dependence in individuals with dementia and associated caregiver upset: psychometric properties of a new scale and response patterns by caregiver and care recipient characteristics. J Aging Health (2005) 1.15

The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. J Neurosci (2012) 1.14

Isolation and characterization of the Xenopus oocyte plasma membrane: a new method for studying activity of water and solute transporters. Am J Physiol Renal Physiol (2005) 1.14

Clinical application of microfluidic leukocyte enrichment protocol in mild phenotype sickle cell disease (SCD). Biomed Microdevices (2009) 1.12

Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. Diabetes Care (2010) 1.10

Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis (2009) 1.10

Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease. J Comput Assist Tomogr (2009) 1.08

Influence of sociodemographic variables on neuropsychological test performance in Spanish-speaking older adults. J Clin Exp Neuropsychol (2007) 1.08

Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes. Ann Behav Med (2011) 1.07

How late-life depression affects cognition: neural mechanisms. Curr Psychiatry Rep (2010) 1.06

Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. Arch Neurol (2010) 1.06

Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. J Infect Dis (2011) 1.05

Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men. Cancer Res (2011) 1.05

Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP. Mol Biol Cell (2009) 1.04

Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men. Cancer Epidemiol Biomarkers Prev (2010) 1.03

Intergenerational transmission of social anxiety: the role of social referencing processes in infancy. Child Dev (2008) 1.00

Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy. Neurobiol Aging (2006) 0.99

Changes in brain volume and cognition in a randomized trial of exercise and social interaction in a community-based sample of non-demented Chinese elders. J Alzheimers Dis (2012) 0.98

Risk factors for incident condyloma in a multinational cohort of men: the HIM study. J Infect Dis (2012) 0.98

Conversion to dementia among two groups with cognitive impairment. A preliminary report. Dement Geriatr Cogn Disord (2004) 0.97

Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions. Alzheimers Res Ther (2010) 0.97

Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiol Aging (2004) 0.97

The effects of maternal social phobia on mother-infant interactions and infant social responsiveness. J Child Psychol Psychiatry (2007) 0.96

Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Brain (2006) 0.96

Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men. Cancer Epidemiol Biomarkers Prev (2012) 0.95

Massage modalities and symptoms reported by cancer patients: narrative review. J Soc Integr Oncol (2008) 0.95

High Blood caffeine levels in MCI linked to lack of progression to dementia. J Alzheimers Dis (2012) 0.95

Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors. Cell Cycle (2011) 0.94

Severity of medial temporal atrophy and amnestic mild cognitive impairment: selecting type and number of memory tests. Am J Geriatr Psychiatry (2009) 0.92

An investigation of PreMCI: subtypes and longitudinal outcomes. Alzheimers Dement (2012) 0.92

Outcome- and auxiliary-dependent subsampling and its statistical inference. J Biopharm Stat (2009) 0.92

Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol (2011) 0.92

Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content. Atherosclerosis (2007) 0.91

Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (2012) 0.90

Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (2011) 0.90

Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients. Brain Disord Ther (2012) 0.89

Assessing the cognitive abilities that differentiate patients with Alzheimer's disease from normals: single and multiple factor models. Int J Geriatr Psychiatry (2004) 0.88

Evaluation of the factor structure and psychometric properties of the Brief Symptom Inventory-18 with homebound older adults. Int J Geriatr Psychiatry (2010) 0.88

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides. BMC Neurosci (2008) 0.88

The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer's disease, MCI and cognitively normal elderly subjects. Front Aging Neurosci (2013) 0.87

Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome. Int J Geriatr Psychiatry (2014) 0.87

Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment. Dement Geriatr Cogn Disord (2011) 0.86